Histone H3K36I mutation in a metastatic histiocytic tumor of the skull and response to sarcoma chemotherapy.


Journal

Cold Spring Harbor molecular case studies
ISSN: 2373-2873
Titre abrégé: Cold Spring Harb Mol Case Stud
Pays: United States
ID NLM: 101660017

Informations de publication

Date de publication:
10 2019
Historique:
received: 14 07 2019
accepted: 30 08 2019
entrez: 25 10 2019
pubmed: 28 10 2019
medline: 21 7 2020
Statut: epublish

Résumé

Recurrent somatic missense mutations in histone H3 genes have been identified in subsets of pediatric cancers. H3K36 histone mutations have recently been recognized as oncogenic drivers in rare subsets of malignant soft tissue sarcomas but have not been reported in histiocytic neoplasms. Currently, the histological and molecular spectrum, as well as the clinical behavior of H3K36-mutant soft tissue malignancies, is largely unknown. We describe a pediatric patient with a

Identifiants

pubmed: 31645348
pii: mcs.a004606
doi: 10.1101/mcs.a004606
pmc: PMC6824254
pii:
doi:

Substances chimiques

Histones 0

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© 2019 Snuderl et al.; Published by Cold Spring Harbor Laboratory Press.

Références

J Clin Exp Hematop. 2013;53(1):1-8
pubmed: 23801128
Mayo Clin Proc. 2014 Jul;89(7):985-96
pubmed: 24814521
Am J Clin Oncol. 1998 Jun;21(3):317-21
pubmed: 9626808
Nat Commun. 2018 Jul 20;9(1):2868
pubmed: 30030436
Br J Ophthalmol. 2004 Jun;88(6):844-7
pubmed: 15148234
Blood. 2010 Nov 18;116(20):4070-6
pubmed: 20724540
Science. 2016 May 13;352(6287):844-9
pubmed: 27174990
Pediatr Blood Cancer. 2014 Mar;61(3):479-87
pubmed: 24106153
Blood. 2012 Sep 27;120(13):2700-3
pubmed: 22879539
Science. 2016 Jun 10;352(6291):1344-8
pubmed: 27229140
Nat Med. 2014 Dec;20(12):1479-84
pubmed: 25384085
BMJ Case Rep. 2013 Apr 15;2013:null
pubmed: 23592809
Nat Genet. 2013 Dec;45(12):1479-82
pubmed: 24162739

Auteurs

Matija Snuderl (M)

Department of Pathology, NYU Langone Medical Center, New York, New York 10016, USA.

Igor Dolgalev (I)

Genome Technology Center, NYU Langone Medical Center, New York, New York 10016, USA.

Adriana Heguy (A)

Department of Pathology, NYU Langone Medical Center, New York, New York 10016, USA.

Michael F Walsh (MF)

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.

Ryma Benayed (R)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.

Achim A Jungbluth (AA)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.

Marc Ladanyi (M)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.

Matthias A Karajannis (MA)

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH